N'-[2-(3-tert-butylphenyl)-1-iminopropan-2-yl]-N-[2-(3-tert-butylphenyl)propan-2-yl]methanediimine
C27H37N3 — CID 163888861
Data last refreshed: (MolForge compound catalog, from PubChem)
About N'-[2-(3-tert-butylphenyl)-1-iminopropan-2-yl]-N-[2-(3-tert-butylphenyl)propan-2-yl]methanediimine
N'-[2-(3-tert-butylphenyl)-1-iminopropan-2-yl]-N-[2-(3-tert-butylphenyl)propan-2-yl]methanediimine (PubChem CID 163888861) has the molecular formula C27H37N3 and a molecular weight of 403.61 g/mol. Its IUPAC name is N'-[2-(3-tert-butylphenyl)-1-iminopropan-2-yl]-N-[2-(3-tert-butylphenyl)propan-2-yl]methanediimine.
Molecular Properties
| Compound Name | N'-[2-(3-tert-butylphenyl)-1-iminopropan-2-yl]-N-[2-(3-tert-butylphenyl)propan-2-yl]methanediimine |
|---|---|
| PubChem CID | 163888861 |
| Molecular Formula | C27H37N3 |
| Molecular Weight | 403.61 g/mol |
| Exact Mass | 403.30 |
| IUPAC Name | N'-[2-(3-tert-butylphenyl)-1-iminopropan-2-yl]-N-[2-(3-tert-butylphenyl)propan-2-yl]methanediimine |
| SMILES | [H]/N=C/C(C)(N=C=NC(C)(C)c1cccc(C(C)(C)C)c1)c1cccc(C(C)(C)C)c1 |
| InChI | InChI=1S/C27H37N3/c1-24(2,3)20-12-10-14-22(16-20)26(7,8)29-19-30-27(9,18-28)23-15-11-13-21(17-23)25(4,5)6/h10-18,28H,1-9H3/b28-18+ |
| InChIKey | PZUYOSQVPAQHKG-MTDXEUNCSA-N |
| XLogP | 7.26 |
| TPSA | 48.57 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 403.61 |
| LogP ≤ 5 | 7.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163888861 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.